What specific gene expression signatures in aging mouse brain predict human AD vulnerability?
PARTIALLY ADDRESSED
The debate was structured to identify aging-neurodegeneration mechanisms using Allen Brain Atlas data cross-referenced with human AD datasets, but no actual hypotheses or gene signatures were generated or analyzed. This represents a critical gap in translating mouse aging models to human neurodegeneration prediction.
Source: Debate session sess_SDA-2026-04-02-gap-aging-mouse-brain-20260402 (Analysis: SDA-2026-04-02-gap-aging-mouse-brain-20260402)
Landscape Summary:
What specific gene expression signatures in aging mouse brain predict human AD vulnerability? is a 0.9 priority gap in neurodegeneration.
It has 0 linked hypotheses with average composite score 0.000.
Status: partially_addressed.
Key Unanswered Questions
What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?
Key Researchers
Colonna, Sevlever, et al. (TREM2 biology)
Clinical Trials
What specific gene expression signatures in aging mouse brain predict human AD vulnerability? — INVOKE-2 (completed)